cloning, reporting, and disseminating

Helen Macdonald, Juan Franco, and Joe Ross are back with our monthly update on the world of evidence based medicine. This episode delves into new methodologies which can use observational data to emulate trial data. We discuss a new systematic review and meta-analysis of RCTs for surgical treatment of sciatica. There is elaboration and explanation of the CONSORT Harms 2022 statement - and we'll be asking if it goes far enough. Finally, the old chestnut of surrogate endpoints in cancer treatment trials - are benefits communicated to patients accurately? Reading list; Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records - Surgical versus non-surgical treatment for sciatica CONSORT Harms 2022 statement, explanation, and elaboration Funders crack down on unpublished clinical trials—but is it enough? Communication of anticancer drug benefits and related uncertainties to patients and clinicians

You can listen to cloning, reporting, and disseminating online on Radio and Podcast. Open the player on this page to stream the available audio.

cloning, reporting, and disseminating is an episode from Talk Evidence by The BMJ.

This episode is 47:02 long.

This episode was published on May 5, 2023.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Talk Evidence when more episodes are available from the podcast feed.